Literature DB >> 9780129

Ethnic differences in drug disposition and response.

A J Wood1.   

Abstract

Interindividual variability in drug response is a well-recognized problem resulting in both undertreatment and overtreatment of individuals receiving similar doses of drugs, with the potential for lack of therapeutic effect and for drug toxicity. The potential that interethnic differences might contribute to such interindividual variability in drug response has recently been recognized. Such interethnic differences in drug response may be due to either altered drug disposition or altered drug sensitivity among races at similar drug concentrations. In turn, such racial differences in drug disposition may be related to genetic or environmental factors, which are often difficult to separate.

Entities:  

Mesh:

Year:  1998        PMID: 9780129     DOI: 10.1097/00007691-199810000-00013

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  10 in total

Review 1.  Recommendations of the clinical trials consensus panel. National Medical Association.

Authors: 
Journal:  J Natl Med Assoc       Date:  2000-10       Impact factor: 1.798

2.  No influence of ethnic origin on the pharmacokinetics and pharmacodynamics of melagatran following oral administration of ximelagatran, a novel oral direct thrombin inhibitor, to healthy male volunteers.

Authors:  Linda C Johansson; Magnus Andersson; Gunnar Fager; David Gustafsson; Ulf G Eriksson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Evaluation of dihydropyrimidine dehydrogenase activity in South-west Asian, Kenyan and Ghanaian populations.

Authors:  J M Morsman; J Sludden; M M Ameyaw; J Githang'A; A Indalo; D Ofori-Adjei; H L McLeod
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

4.  Influence of hydroxychloroquine on the bioavailability of oral metoprolol.

Authors:  M Somer; J Kallio; U Pesonen; K Pyykkö; R Huupponen; M Scheinin
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

Review 5.  Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.

Authors:  Jörn Lötsch; Carsten Skarke; Jürgen Liefhold; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 6.  Racial differences in blood pressure response to calcium channel blocker monotherapy: a meta-analysis.

Authors:  Thu T Nguyen; Jay S Kaufman; Eric A Whitsel; Richard S Cooper
Journal:  Am J Hypertens       Date:  2009-06-04       Impact factor: 2.689

7.  Pharmacokinetic and Pharmacodynamic Analyses of 5-Fluorouracil in East-Asian Patients with Nasopharyngeal Carcinoma.

Authors:  Yuxiang Ma; Yuehao Lin; Benyan Zou; Wanli Liu; Yang Zhang; Liping Zhao; Yan Huang; Yunpeng Yang; Wenfeng Fang; Yuanyuan Zhao; Jin Sheng; Tao Qin; Zhihuang Hu; Salavatore J Salamone; Yunying Li; Li Zhang; Hongyun Zhao
Journal:  Clin Pharmacokinet       Date:  2016-10       Impact factor: 6.447

8.  Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes.

Authors:  T M Davis; F Daly; J P Walsh; K F Ilett; J P Beilby; L J Dusci; P H Barrett
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

9.  Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.

Authors:  Shabana Ali; Muzammil H Najmi; Joel Tarning; Niklas Lindegardh
Journal:  Malar J       Date:  2010-10-11       Impact factor: 2.979

10.  Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects.

Authors:  Satoru Inoue; Soniya Vaidya; Hanns-Christian Tillmann; Yohei Sakita; Surendra Machineni; Olivier Heudi; Kenichi Furihata
Journal:  BMC Pulm Med       Date:  2021-01-07       Impact factor: 3.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.